No definition available.
Congenital absence, occlusion, or narrowing of the ear canal
Q17_CONGENITAL_ABSENCE_OCCLUSION_OR_NARROWING_OF_THE_EAR_CANAL
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
557745 |
1. Apply sex-specific ruleNone |
557745 |
2. Check conditionsNone |
557745 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
74 |
4. Check minimum number of eventsNone |
74 |
5. Include endpointsNone |
74 |
6. Filter based on genotype QC (FinnGen only) |
70 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Similar endpoints
↥List of similar endpoints to
Congenital absence, occlusion, or narrowing of the ear canal
based on the number of shared cases.
Similar with more cases:
- Congenital malformations of ear causing impairment of hearing
- Congenital malformations of eye, ear, face and neck
- Congenital malformations, deformations and chromosomal abnormalities
- Congenital malformations, deformations and chromosomal abnormalities, including avohilmo
- Any operation in hilmo
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded (different definition than used in FinnGen).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 70 | 40 | 30 |
| Unadjusted period prevalence (%) | 0.01 | 0.01 | 0.01 |
| Median age at first event (years) | 25.72 | 18.27 | 35.65 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 71
- Matched controls
- 710
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
Q16.1
ICD-10 Finland
Congenital absence, atresia and stricture of auditory canal (external)
+∞
102.0
71
*
Q17.2
ICD-10 Finland
Microtia
292.4
21.9
21
*
H90.1
ICD-10 Finland
Conductive hearing loss, unilateral with unrestricted hearing on the contralateral side
136.5
19.7
20
*
DBD20
NOMESCO Finland
Plastic repair of external auditory canal
254.5
19.6
19
*
UDC00
NOMESCO Finland
Ear microscopy
19.3
17.9
28
23
Z01.1
ICD-10 Finland
Examination of ears and hearing
7.9
15.4
28
54
H90.3
ICD-10 Finland
Sensorineural hearing loss, bilateral
8.8
15.3
24
39
H90.6
ICD-10 Finland
Mixed conductive and sensorineural hearing loss, bilateral
101.4
15.3
16
*
Q16.0
ICD-10 Finland
Congenital absence of (ear) auricle
+∞
14.0
13
*
DC1AD
NOMESCO Finland
Temporalbone CT
78.2
12.0
13
*
H90.0
ICD-10 Finland
Conductive hearing loss, bilateral
78.2
12.0
13
*
DFF00
NOMESCO Finland
Pure tone audiometry
10.5
11.0
22
29
DBD30
NOMESCO Finland
Correction of atresia of external auditory canal
+∞
10.7
10
*
DAX00
NOMESCO Finland
Adjustment or review of hearing aid
15.5
10.0
16
13
DAD10
NOMESCO Finland
Reconstruction of auricle
57.3
8.9
10
*
DEE00
NOMESCO Finland
Osseous fixation of hearing aid
101.6
8.6
9
*
H90.7
ICD-10 Finland
Mixed conductive and sensorineural hearing loss, unilateral with unrestricted hearing on the contralateral side
89.0
7.6
8
*
ZZG00
NOMESCO Finland
Graft of cartilage
+∞
7.4
7
*
H61.3
ICD-10 Finland
Acquired stenosis of external ear canal
76.4
6.5
7
*
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
6.2
6.4
17
34
7440A
ICD-9 Finland
Congenital anomalies of ear, face and neck, Anomalies of ear causing impairment of hearing[ATRESIA AURIS]
+∞
6.3
6
*
Z97.4
ICD-10 Finland
Presence of external hearing-aid
16.9
6.1
9
6
ZXA05
NOMESCO Finland
Left side
3.9
6.0
22
73
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
12
53
2.52
1.93
2.0
2.9
—
—
—
0
0
18
292
0.49
1.86
3.3
3.2
66.08
70.61
nmol/l
0.43
18
270
6
126
0.43
1.33
1.2
1.5
—
—
—
0
0
20
266
0.65
0.81
3.2
9.8
1.22
1.22
mmol/l
0.15
20
249
0
22
0.00
0.60
0.0
1.9
—
—
—
0
0
0
22
0.00
0.60
0.0
2.8
—
—
—
0
0
0
23
0.00
0.59
0.0
1.9
—
—
—
0
0
49
536
0.72
0.54
3.3
3.8
—
—
—
0
0
6
95
0.60
0.45
1.8
7.2
3.33
6.26
umol/l
—
6
79
53
568
0.74
0.44
13.7
18.9
334.34
333.95
g/l
0.14
53
568
7
103
0.64
0.43
4.9
10.4
0.98
1.13
mmol/l
—
7
96
5
32
1.60
0.43
1.4
1.4
—
—
—
0
0
7
105
0.63
0.43
1.3
7.8
0.81
0.81
mmol/l
—
7
97
0
15
0.00
0.41
0.0
2.2
—
—
—
0
0
0
17
0.00
0.41
0.0
1.8
—
—
—
0
0
0
17
0.00
0.41
0.0
1.2
—
—
—
0
0
0
17
0.00
0.41
0.0
2.1
—
—
—
0
0
20
241
0.76
0.40
1.5
1.8
91.62
97.36
pmol/l
0.23
11
131
0
19
0.00
0.39
0.0
2.3
—
7.49
—
0
19
0
19
0.00
0.39
0.0
1.2
—
—
—
0
0
0
19
0.00
0.39
0.0
1.4
—
—
—
0
0
52
556
0.76
0.39
3.9
4.4
4.74
4.54
mmol/l
0.85
52
526
52
556
0.76
0.39
3.6
4.3
1.49
1.43
mmol/l
0.59
52
525
21
246
0.79
0.33
3.5
6.7
37.49
37.15
g/l
0.11
21
239
14
172
0.77
0.32
3.9
2.4
—
—
—
0
0
19
224
0.79
0.31
2.2
4.3
—
—
—
0
0
53
560
0.79
0.30
4.1
4.7
2.84
2.68
mmol/l
0.72
53
531
5
39
1.30
0.23
1.2
1.7
—
—
—
0
0
24
213
1.19
0.22
1.3
1.6
0.64
2.24
u/ml
—
8
42
13
108
1.25
0.22
2.5
3.0
10.24
14.45
umol/l
2.68
13
101
0
11
0.00
0.21
0.0
2.1
—
—
—
0
0
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
0
12
0.00
0.21
0.0
1.7
—
—
—
0
0
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
26
287
0.85
0.21
2.3
3.1
—
—
estimate
—
0
0
0
13
0.00
0.21
0.0
3.9
—
0.00
—
0
13
31
337
0.86
0.20
2.1
3.7
0.00
0.00
estimate
—
6
65
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
0
14
0.00
0.20
0.0
3.7
—
0.00
—
0
14
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
12
100
1.24
0.19
1.4
2.0
—
—
—
0
0
6
52
1.17
0.19
2.2
1.4
—
—
—
0
0
15
173
0.83
0.19
2.3
3.6
0.00
0.00
estimate
—
6
61
5
67
0.73
0.18
4.8
12.4
107.60
103.93
mmol/l
—
5
67
32
343
0.88
0.16
2.1
3.8
0.00
0.00
estimate
—
6
62
7
89
0.76
0.15
1.7
1.6
900.83
831.82
mu/l
—
7
77
8
96
0.81
0.15
2.9
2.5
2.45
2.43
mmol/l
—
8
84
13
148
0.85
0.14
1.5
2.9
—
—
—
0
0
12
104
1.19
0.13
2.2
2.3
—
—
—
0
0
10
85
1.21
0.13
1.9
2.2
—
—
—
0
0
17
187
0.88
0.12
3.2
3.6
17.00
60.68
ng/l
—
8
109
14
155
0.88
0.10
3.4
2.3
—
—
—
0
0
5
45
1.12
0.10
1.0
4.5
1.98
5.50
ug/l
—
5
35
6
70
0.84
0.08
1.8
1.8
—
—
—
0
0
53
540
0.93
0.04
9.4
12.4
95.81
94.46
ml/min/173m2
0.15
46
473
33
340
0.95
0.04
2.1
3.8
0.00
0.00
estimate
—
7
63
11
117
0.93
0.02
1.5
1.3
2.90
6.71
u/ml
—
5
42
24
241
0.99
0.00
2.1
3.4
0.00
0.00
estimate
—
5
53
22
222
0.99
0.00
1.7
1.7
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
7
0.00
-0.00
0.0
3.0
—
—
—
0
0
35
350
1.00
-0.00
3.3
6.4
6.24
6.27
mmol/l
0.04
30
327
0
9
0.00
-0.00
0.0
2.0
—
25.70
—
0
9
0
7
0.00
-0.00
0.0
3.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
7.2
—
—
—
0
0
0
8
0.00
-0.00
0.0
2.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
2.2
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
2.2
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
7
0.00
-0.00
0.0
2.6
—
—
—
0
0
0
7
0.00
-0.00
0.0
2.6
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
2.0
—
13.40
—
0
5
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
63
626
1.06
-0.00
10.4
14.3
27.63
20.33
mg/l
0.64
50
488
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
7
75
0.93
-0.00
1.7
1.6
—
—
—
0
0
0
7
0.00
-0.00
0.0
3.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.5
—
15.29
—
0
8
0
9
0.00
-0.00
0.0
1.6
—
—
—
0
0
0
6
0.00
-0.00
0.0
2.8
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
3.0
—
—
—
0
0
7
69
1.02
-0.00
4.9
15.1
23.47
24.99
mmol/l
—
7
69
0
6
0.00
-0.00
0.0
1.5
—
—
—
0
0
0
7
0.00
-0.00
0.0
3.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
2.6
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
2.2
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.5
—
—
—
0
0
0
6
0.00
-0.00
0.0
2.8
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.5
—
1.13
—
0
6
0
6
0.00
-0.00
0.0
1.0
—
2.32
—
0
6
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
5.3
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
5
57
0.87
-0.00
1.8
4.1
37.40
30.88
%
—
5
41
0
6
0.00
-0.00
0.0
2.8
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.6
—
—
—
0
0
0
7
0.00
-0.00
0.0
2.6
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
5
0.00
-0.00
0.0
2.4
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.4
—
44.37
—
0
7
0
7
0.00
-0.00
0.0
3.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
5.3
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded (different definition than used in FinnGen).
Relationships between endpoints
↥Index endpoint: Q17_CONGENITAL_ABSENCE_OCCLUSION_OR_NARROWING_OF_THE_EAR_CANAL – Congenital absence, occlusion, or narrowing of the ear canal
GWS hits: -
This endpoint is excluded (different definition than used in FinnGen).